Repository

• Home
• Repository
• Publications

Publications

NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts Amengual J, Gonzalez-Sanchez E, Yáñez-Bartolome M, Sererols-Viñas L, Ravichandra A, Guiton C, Fuste NP, Alay A, Hijazo-Pechero S, Martín-Mur B, Gut M, Esteve-Codina A, Cantos-Cortes A, Espinosa-Sotelo R, Ramos E, Serrano T, Calvo M, Laquente B, Ferrer J, Pons G, Mendez-Lucas A, Dooley S, Ilyas SI, Vallette M, Aoudjehane L, Lequoy M, Fouassier L, Coulouarn C, Affò S, Scheiter A, Calvisi DF, Tian TV, Fabregat I, Vaquero J. Signal Transduct Target Ther. 2025 Aug 18;10(1):257. doi: 10.1038/s41392-025-02347-z 2025  Result from   OA Funded by

Beyond Post hoc Explanations: A Comprehensive Framework for Accountable AI in Medical Imaging Through Transparency, Interpretability, and Explainability Singh Y, Hathaway QA, Keishing V, Salehi S, Wei Y, Horvat N, Vera-Garcia DV, Choudhary A, Kh AM, Quaia E, Andersen JB Bioengineering (Basel) . 2025 Aug 15;12(8):879. doi: 10.3390/bioengineering12080879 2025  Results from

Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential Mercado-Gómez M, Goikoetxea-Usandizaga N, Giné AE, Merlos Rodrigo MA, Afonso MB, Azkargorta M, Zapata-Pavas LE, Rejano-Gordillo CM, Romero MR, Mendizabal I, Rodrigues PM, Wu H, Rodríguez-Agudo R, Serrano-Maciá M, Olaizola P, Barrenechea-Barrenechea JA, González Recio I, G Fernandez-Barrena M, Overi D, Gaudio E, Schaeper U, Garcia-Longarte S, Yáñez-Bartolomé M, Peña-SanFelix P, Gil-Pitarch C, Lapitz A, Michalkova H, Heger Z, Conter C, Macias RIR, Carracedo A, Bañales J, Moreno V, Lamarca A, Singh R, Delgado TC, Martínez-Cruz LA, Elortza F, Avila MA, Martín C, Tian TV, Macarulla T, Buccella D, Cubero FJ, Calvisi DF, Carpino G, Marin JJG, Rodrigues CMP, Martinez-Chantar ML Gut. 2026 Jan 8;75(2):341-352. doi: 10.1136/gutjnl-2024-333255 2026  Result from   OA Funded by

Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs Delgado-Calvo K, Lozano E, Briz O, Cives-Losada C, Marin JJG, Macias RIR Molecules. 2025 Jul 21;30(14):3053. doi: 10.3390/molecules30143053 2025  Result from

A novel naphthoquinone compound triggers DNA damage-induced apoptosis on cholangiocarcinoma through upregulation of BAX Bulut G, Kayis M, Gezer D, Gokmen Z, Adiguzel Z, Raggi C, Ulukaya E. Med Oncol. 2025 Jul 20;42(8):354. doi: 10.1007/s12032-025-02927-7 2025  Result from